We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+7.97%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$27.3B
AUM Growth
+$1.17B
(+4.5%)
Cap. Flow
-$1B
Cap. Flow
% of AUM
-3.68%
Top 10 Holdings %
Top 10 Hldgs %
13.33%
Holding
1,440
New
99
Increased
518
Reduced
438
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$58.6M |
| 2 |
Charter Communications
CHTR
|
+$45.8M |
| 3 |
Credit Acceptance
CACC
|
+$44.9M |
| 4 |
Home Depot
HD
|
+$43M |
| 5 |
Autodesk
ADSK
|
+$40.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$77.5M |
| 2 |
Apple
AAPL
|
+$73.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$64.7M |
| 4 |
Merck
MRK
|
+$58.9M |
| 5 |
Qualcomm
QCOM
|
+$56.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 16.1% |
| 3 | Financials | 11.41% |
| 4 | Consumer Discretionary | 10.23% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Booz Allen Hamilton
BAH
$9.63B
| $1.31M | ﹤0.01% |
26,500
-204,800
| -89% | -$9.99M |
|
952
Hurco Companies Inc
HURC
$146M
| $1.31M | ﹤0.01% |
29,150
| – | – |
|
|
TBI
953
Trueblue
TBI
$276M
| $1.31M | ﹤0.01% |
50,300
+9,500
| +23% | +$264K |
|
954
Enanta Pharmaceuticals
ENTA
$358M
| $1.31M | ﹤0.01% |
15,300
-2,100
| -12% | -$210K |
|
955
TC Energy
TRP
$63.6B
| $1.31M | ﹤0.01% |
32,290
+4,000
| +14% | +$173K |
|
|
CHK
956
DELISTED
Chesapeake Energy Corporation
CHK
| $1.3M | ﹤0.01% |
+1,443
| New | +$1.32M |
|
957
Asbury Automotive
ABG
$3.68B
| $1.29M | ﹤0.01% |
18,800
+8,900
| +90% | +$641K |
|
958
Cirrus Logic
CRUS
$6.12B
| $1.29M | ﹤0.01% |
33,400
-5,550
| -14% | -$230K |
|
|
SRNE
959
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.28M | ﹤0.01% |
290,100
+219,500
| +311% | +$1.22M |
|
960
Vipshop
VIPS
$5.75B
| $1.27M | ﹤0.01% |
203,945
+163,938
| +410% | +$1.35M |
|
961
Match Group
MTCH
$10.2B
| $1.27M | ﹤0.01% |
21,917
-32,500
| -60% | -$1.52M |
|
962
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$429M
| $1.26M | ﹤0.01% |
50,820
+2,990
| +6% | +$74.1K |
|
963
Americold
COLD
$4.28B
| $1.25M | ﹤0.01% |
+50,000
| New | +$1.16M |
|
964
LCI Industries
LCII
$2.13B
| $1.25M | ﹤0.01% |
15,114
+70
| +0.5% | +$6.55K |
|
|
CMRX
965
DELISTED
Chimerix, Inc.
CMRX
| $1.24M | ﹤0.01% |
319,073
| – | – |
|
966
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.59B
| $1.24M | ﹤0.01% |
20,910
+1,260
| +6% | +$73.9K |
|
967
Lumen
LUMN
$7.04B
| $1.24M | ﹤0.01% |
58,487
+14,900
| +34% | +$312K |
|
968
PJT Partners
PJT
$3.97B
| $1.23M | ﹤0.01% |
23,452
| – | – |
|
969
Boise Cascade
BCC
$2.65B
| $1.23M | ﹤0.01% |
33,300
+5,100
| +18% | +$222K |
|
970
Rollins
ROL
$16.2B
| $1.22M | ﹤0.01% |
+45,054
| New | +$1.16M |
|
971
Alcoa
AA
$12.3B
| $1.21M | ﹤0.01% |
30,000
-1,600
| -5% | -$69.5K |
|
972
EnerSys
ENS
$6.15B
| $1.21M | ﹤0.01% |
13,900
| – | – |
|
973
Evertec
EVTC
$1.69B
| $1.2M | ﹤0.01% |
49,800
-22,500
| -31% | -$533K |
|
974
Range Resources
RRC
$9.79B
| $1.19M | ﹤0.01% |
70,032
-7,300
| -9% | -$117K |
|
975
Raymond James Financial
RJF
$32.5B
| $1.19M | ﹤0.01% |
19,307
| – | – |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q3 2018 Portfolio in Review
As of Q3 2018, Axa held 1,440 positions worth $27.3B, up 4.5% from $26.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Axa withdrew a net $1B in Q3 2018, closing 115 positions and reducing 438 holdings. Its most notable exit was CA, Inc., an estimated $56.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in KKR & Co worth $27.3M.
- Axa's largest Q3 2018 buy was KKR & Co: 1,000,000 shares worth $27.3M.
- Axa added most to Intel in Q3 2018, an estimated $58.6M increase.
- Axa's biggest Q3 2018 reduction was DexCom, cutting an estimated $77.5M.
- Axa fully exited CA, Inc. in Q3 2018, selling an estimated $56.1M.
- Axa's ten largest holdings make up 13% of its $27.3B portfolio in Q3 2018.
- Axa opened 99 new positions and closed 115 in Q3 2018.
- Axa's portfolio value rose 4.5% quarter-over-quarter to $27.3B.
Based on Axa's 13F filing for Q3 2018, filed 8 Nov 2018.